ARI103094-Follow-Up Study for REDUCE Study Subjects
NCT00883909
·
clinicaltrials.gov ↗
COMPLETED
Status
2795
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms, Prostate
Interventions
DRUG:
dutasteride
Sponsor
GlaxoSmithKline